6550--NOITSS - Zeus Scientific Borrelia MTTT Lyme Elisa Testing

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

241-NETWORK CONTRACT OFFICE 01 (36C241)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24126Q0634

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Brockton, Massachusetts, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, VISN 1, Pathology and Laboratory Medicine Service (P&LMS) has issued a Special Notice regarding its intent to establish a five-year Blanket Purchase Agreement (BPA) for Borrelia MTTT Lyme Testing Reagents and Supplies. This procurement is specifically intended to support the Dynex Agility® Automated ELISA System, which is currently owned and operated at the VA Connecticut Medical Center. The reagents and supplies will be ordered on an as-needed basis throughout the contract period, which spans from September 28, 2026, to September 27, 2031, divided into five annual performance periods. The primary objective of this procurement is to ensure the continued availability of FDA-approved, US-manufactured Lyme testing reagents and supplies that are fully compatible with the Dynex Agility Automated ELISA System. These products are essential for the accurate and efficient diagnosis of Lyme disease within the VA medical facility, supporting the Pathology and Laboratory Medicine Service’s mission to deliver high-quality diagnostic services to veterans. A key requirement is that all assays must be FDA-approved and manufactured in the United States, ensuring compliance with regulatory standards and supporting domestic production. The notice clarifies that Zeus Scientific remains the only vendor capable of providing all required products, and these are manufactured in the US. However, an amendment to the original notice corrects the intended awardee from Zeus Scientific to its parent company, Sebia Inc. No other aspects of the Notice of Intent to Sole Source (NOITSS) have changed, and the items listed in the original notice remain unchanged. This procurement is being conducted under the authority of FAR 13.5, which allows for Simplified Procedures for Certain Commercial Products and Commercial Services, referencing 10 U.S.C. 3205-3208 and 41 U.S.C. 3305. The intent is to award this requirement on a sole-source basis, and as such, no solicitation will be posted to Contract Opportunities. The notice explicitly states that this is not a request for competitive proposals, and requests for a solicitation will not receive a response. The North American Industry Classification System (NAICS) code associated with this requirement is 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing. The Product Service Code is 6550. The place of performance is Brockton, Massachusetts, within the United States. The contracting entity responsible for this procurement is the 241-Network Contract Office 01 (36C241), a federal office under the Department of Veterans Affairs. The primary point of contact for this notice is Sarah Otis, who can be reached at [email protected] or by phone at 774-826-4929. Contractors who believe they are qualified to provide the specified products are invited to submit a response by July 22nd, 3:00 PM (EST), including detailed and relevant documentation to enable the government to conduct adequate market research and make a proper determination. Any information received will be considered solely for the purpose of determining whether a competitive procurement is warranted. The government reserves the sole discretion to decide whether to compete this requirement based on responses received. This opportunity is best suited for vendors with proven capabilities in manufacturing FDA-approved, US-made in-vitro diagnostic substances compatible with the Dynex Agility Automated ELISA System. The contract’s requirements and scope are expected to remain constant throughout its lifecycle, focusing on the reliable supply of Lyme testing reagents and supplies for the VA’s laboratory operations. For further details and to review the official notice, interested parties may visit the SAM.gov opportunity page at https://sam.gov/opp/b3f6bcc6002c4b13b19eb34f43d17518/view.